Mark J Boschen1. 1. School of Psychology and Griffith Health Institute, Griffith University, Southport Queensland, Australia. m.boschen@griffith.edu.au
Abstract
OBJECTIVE: Generalized anxiety disorder (GAD) is a chronic anxiety disorder that leads to significant functional impairment and reduced quality of life. Pregabalin is a novel analogue of the inhibitory neurotransmitter gamma amino butyric acid, which has been proposed as a treatment for a range of conditions including GAD. This study examined the efficacy of pregabalin for GAD across published trials, using a meta-analytic method. METHOD: This study examined the 7 published placebo-controlled trials of GAD using pregabalin, and, using meta-analytic techniques, we calculated the effect size of treatment with pregabalin (compared with placebo) on a total of 1352 people. RESULTS: The overall effect size of pregabalin in the treatment of GAD was Hedges' g = 0.364, with an effect size of 0.349 on psychic anxiety symptoms and of 0.239 on somatic anxiety symptoms. CONCLUSION: Pregabalin is an efficacious therapy for GAD, although effect sizes are smaller than those from earlier studies. Limitations and future research directions are discussed.
OBJECTIVE:Generalized anxiety disorder (GAD) is a chronic anxiety disorder that leads to significant functional impairment and reduced quality of life. Pregabalin is a novel analogue of the inhibitory neurotransmitter gamma amino butyric acid, which has been proposed as a treatment for a range of conditions including GAD. This study examined the efficacy of pregabalin for GAD across published trials, using a meta-analytic method. METHOD: This study examined the 7 published placebo-controlled trials of GAD using pregabalin, and, using meta-analytic techniques, we calculated the effect size of treatment with pregabalin (compared with placebo) on a total of 1352 people. RESULTS: The overall effect size of pregabalin in the treatment of GAD was Hedges' g = 0.364, with an effect size of 0.349 on psychic anxiety symptoms and of 0.239 on somatic anxiety symptoms. CONCLUSION:Pregabalin is an efficacious therapy for GAD, although effect sizes are smaller than those from earlier studies. Limitations and future research directions are discussed.
Authors: Jeffrey R Strawn; Laura Geracioti; Neil Rajdev; Kelly Clemenza; Amir Levine Journal: Expert Opin Pharmacother Date: 2018-07 Impact factor: 3.889
Authors: Yusuf S Althobaiti; Farooq M Almutairi; Fahad S Alshehri; Ebtehal Altowairqi; Aliyah M Marghalani; Amal A Alghorabi; Walaa F Alsanie; Ahmed Gaber; Hashem O Alsaab; Atiah H Almalki; Alqassem Y Hakami; Turki Alkhalifa; Ahmad D Almalki; Ana M G Hardy; Zahoor A Shah Journal: Sci Rep Date: 2021-05-19 Impact factor: 4.379
Authors: Yusuf S Althobaiti; Atiah Almalki; Hashem Alsaab; Walaa Alsanie; Ahmed Gaber; Qasim Alhadidi; Ana Maria Gregio Hardy; Abdulrahman Nasr; Omar Alzahrani; Creed M Stary; Zahoor A Shah Journal: Sci Rep Date: 2019-10-22 Impact factor: 4.379
Authors: Atiah H Almalki; Hashem O Alsaab; Walaa F Alsanie; Ahmed Gaber; Turki Alkhalifa; Ahmad Almalki; Omar Alzahrani; Ana Maria Gregio Hardy; Qasim Alhadidi; Zahoor A Shah; Yusuf S Althobaiti Journal: Healthcare (Basel) Date: 2021-03-29